Literature DB >> 26302144

Methamphetamine Cardiotoxicity: Unique Presentation with Multiple Bi-Ventricular Thrombi.

Rajesh Janardhanan1, Arun Kannan2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26302144     DOI: 10.1016/j.amjmed.2015.08.006

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  6 in total

1.  Multiple Biventricular Thrombi Associated With Methamphetamine-Associated Cardiomyopathy.

Authors:  Syeda H Zaidi; Umair A Khan; Shazib Sagheer; Abubaker Sheikh; Mark E Garcia
Journal:  Ochsner J       Date:  2022

2.  Repeated Forced Swim Exacerbates Methamphetamine-Induced Neurotoxicity: Neuroprotective Effects of Nanowired Delivery of 5-HT3-Receptor Antagonist Ondansetron.

Authors:  José Vicente Lafuente; Aruna Sharma; Dafin F Muresanu; Asya Ozkizilcik; Z Ryan Tian; Ranjana Patnaik; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 3.  Adrenal infarction secondary to methamphetamine use: a case report and review of the literature.

Authors:  Surendra Sapkota; Sarah David; Sandipa Sharma; Suraj Shrestha; Abhishek Kalla
Journal:  J Med Case Rep       Date:  2022-10-18

Review 4.  Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review.

Authors:  Pavan K V Reddy; Tien M H Ng; Esther E Oh; Gassan Moady; Uri Elkayam
Journal:  J Am Heart Assoc       Date:  2020-05-29       Impact factor: 5.501

Review 5.  Methamphetamine-related cardiovascular diseases.

Authors:  Valentin Schwarzbach; Karsten Lenk; Ulrich Laufs
Journal:  ESC Heart Fail       Date:  2020-01-17

6.  Pharmacological Characterization of 4-Methylthioamphetamine Derivatives.

Authors:  Fabrizzio G Guajardo; Victoria B Velásquez; Daniela Raby; Gabriel Núñez-Vivanco; Patricio Iturriaga-Vásquez; Rodrigo A España; Miguel Reyes-Parada; Ramón Sotomayor-Zárate
Journal:  Molecules       Date:  2020-11-13       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.